# Amgen Inc. (AMGN) — Q4-2015 Earnings Results

**Report date:** 2016-01-28 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2015

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.4%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.61 | N/A | +15.03% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's future prospects. They highlighted the importance of their ongoing projects and the potential for future growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a strong EPS performance, beating expectations by over 15%. However, the stock reacted negatively, declining by 1.4%. The lack of revenue figures and guidance may have contributed to investor uncertainty, overshadowing the positive EPS surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2015_